医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega to Celebrate the Grand Opening of Its New cGMP Facility, Feynman Center, on October 11, 2013

2013年07月09日 PM10:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Promega to celebrate the Grand Opening of its new cGMP facility, Feynman Center, on October 11, 2013. (Photo: Business Wire)Promega to celebrate the Grand Opening of its new cGMP facility, Feynman Center, on October 11, 2013. (Photo: Business Wire)

View and Share Photo

Close Window


MADISON, Wis.

On October 11, 2013, Promega Corporation will host a grand opening celebration to unveil its new cGMP manufacturing facility, the Feynman Center, dedicated to serving customers who need molecular biology reagents for in vitro diagnostic (IVD) assays. This includes components such as sample preparation systems and reagents, which can be used in molecular diagnostic tests provided by other IVD medical device manufacturers.

Promega to celebrate the Grand Opening of its new cGMP facility, Feynman Center, on October 11, 2013 ...

Promega to celebrate the Grand Opening of its new cGMP facility, Feynman Center, on October 11, 2013. (Photo: Business Wire)

WHAT:     The Promega Feynman Center is a state-of-the-art 260,000-square-foot complex dedicated to manufacturing molecular technology tools on both committed (fixed) production lines and flexible manufacturing areas. The building will also have a customer experience center for employees and guests that will include spaces for training, laboratory demonstrations, conferences, an exercise and fitness center and dining.
 
WHO: The event is open to the public, including community leaders, the scientific community and Promega employees and their families.
 
WHERE: Promega Feynman Center
2780 Woods Hollow Road, Fitchburg, WI, 53711
 
WHEN: October 11, 2013
 
WHY: The grand opening provides an opportunity to tour an operation of this kind and to learn more about the science behind molecular tools and technologies. The event will feature guest speakers, behind-the-scenes facility tours and refreshments.
 

About Promega

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics, and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130709005206/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

同じカテゴリーの記事 

  • Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)